Table 2 Psychostimulant use and buprenorphine treatment retention (N = 143)
From: The impact of psychostimulant use on office based buprenorphine treatment retention
Psychostimulant Use | |||
| Â | One Month | Three Months | Six Months |
Cocaine | 18.9% | 4.9% | 4.20% |
Methamphetamine | 13.3% | 7.7% | 3.5% |
Either Cocaine or Methamphetamine | 29.4% | 10.5% | 7.7% |
Retention in Buprenorphine Treatment | |||
One Month | 60.1% | ||
Three Month | 34.3% | ||
Six Month | 31.5% | ||